Contrast-induced acute kidney injury: The at-risk patient and protective measures

Current Cardiology Reports

Volumn 12, Issue 5, 2010, Pages 440-445

  Thompson, Craig A ^a   Brown, Jeremiah R ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

Author keywords

Cardiac catheterization; Kidney injury; Nephropathy; Prevention; Radiocontrast; Risk factors

Indexed keywords

ACETYLCYSTEINE; ATORVASTATIN; BICARBONATE; CREATININE; CYSTATIN C; INTERLEUKIN 18; KIDNEY INJURY MOLECULE 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SIMVASTATIN; SODIUM CHLORIDE; THEOPHYLLINE;

AGE DISTRIBUTION; ANEMIA; AORTA BALLOON; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTRAST INDUCED ACUTE KIDNEY INJURY; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; GENDER; GLOMERULUS FILTRATION RATE; HEART CATHETERIZATION; HUMAN; HYPOTENSION; KIDNEY INJURY; META ANALYSIS; PATIENT SAFETY; REVIEW; RISK FACTOR;

ACETYLCYSTEINE; ACUTE KIDNEY INJURY; BIOLOGICAL MARKERS; CONTRAST MEDIA; DRUG THERAPY, COMBINATION; FREE RADICAL SCAVENGERS; HEART CATHETERIZATION; HUMANS; HYDROTHERAPY; RISK ASSESSMENT; RISK FACTORS; SODIUM BICARBONATE;

EID: 77956267514     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-010-0129-2     Document Type: Review

References (39)

1. CJ DeFrances MJ Hall 2005 National Hospital Discharge Survey Adv Data 2007 385 1 19
2. National Center for Health Statistics: Health, United States, 2009: With Special Feature on Medical Technology. Hyattsville, MD: National Center for Health Statistics; 2010.
3. SM Bagshaw WA Ghali 2004 Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: a systematic review and meta-analysis BMC Med 2 38 10.1186/1741-7015-2-38 15500690
4. J Tumlin F Stacul A Adam, et al. 2006 Pathophysiology of contrast-induced nephropathy Am J Cardiol 98 14K 20K 10.1016/j.amjcard.2006.01.020 1:CAS:528:DC%2BD28XhtVyqurbF 16949376
5. G Romano C Briguori C Quintavalle, et al. 2008 Contrast agents and renal cell apoptosis Eur Heart J 29 2569 2576 10.1093/eurheartj/ehn197 1:CAS:528:DC%2BD1cXhsVSjur7P 18468994 This paper demonstrates the association between contrast dye and renal cell death
6. JR Brown DJ Malenka JT DeVries, et al. 2008 Transient and persistent renal dysfunction are predictors of survival after percutaneous coronary intervention: insights from the Dartmouth Dynamic Registry Catheter Cardiovasc Interv 72 347 354 10.1002/ccd.21619 18729173 This paper demonstrates the poor survival associated with both transient and persistent CI-AKI
7. CP Taliercio RE Vlietstra LD Fisher JC Burnett 1986 Risks for renal dysfunction with cardiac angiography Ann Intern Med 104 501 504 1:STN:280:DyaL287lslaitg%3D%3D 3954277
8. R Mehran ED Aymong E Nikolsky, et al. 2004 A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation J Am Coll Cardiol 44 1393 1399 15464318
9. JR Brown JT DeVries WD Piper, et al. 2008 Serious renal dysfunction after percutaneous coronary interventions can be predicted Am Heart J 155 260 266 10.1016/j.ahj.2007.10.007 18215595 This is a paper for predicting CI-AKI prior to PCI
10. JM Stolker PA McCullough S Rao, et al. 2010 Pre-procedural glucose levels and the risk for contrast-induced acute kidney injury in patients undergoing coronary angiography J Am Coll Cardiol 55 1433 1440 10.1016/j.jacc.2009.09.072 1:CAS:528:DC%2BC3cXlvVKhsL8%3D 20359592 This paper suggests baseline hyperglycemia is a risk factor for CI-AKI
11. JR Brown CA Block DJ Malenka, et al. 2009 Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis JACC Cardiovasc Interv 2 1116 1124 10.1016/j.jcin.2009.07.015 19926054 This is a meta-analysis for the combination therapy of sodium bicarbonate plus N-acetylcysteine
12. S Zoungas T Ninomiya R Huxley, et al. 2009 Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy Ann Intern Med 151 631 638 19884624 This paper and the papers by Meier et al. [13] and Kanbay et al. [14] are recent systematic reviews and meta-analyses of sodium bicarbonate and CI-AKI
13. P Meier DT Ko A Tamura, et al. 2009 Sodium bicarbonate-based hydration prevents contrast-induced nephropathy: a meta-analysis BMC Med 7 23 10.1186/1741-7015-7-23 19439062
14. M Kanbay A Covic SG Coca, et al. 2009 Sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of 17 randomized trials Int Urol Nephrol 41 617 627 10.1007/s11255-009-9569-2 1:CAS:528:DC%2BD1MXns1Cgurg%3D 19396567
15. GM Chertow E Burdick M Honour, et al. 2005 Acute kidney injury, mortality, length of stay, and costs in hospitalized patients J Am Soc Nephrol 16 3365 3370 10.1681/ASN.2004090740 16177006
16. A Tamura Y Goto K Miyamoto, et al. 2009 Efficacy of single-bolus administration of sodium bicarbonate to prevent contrast-induced nephropathy in patients with mild renal insufficiency undergoing an elective coronary procedure Am J Cardiol 104 921 925 10.1016/j.amjcard.2009.05.034 1:CAS:528: DC%2BD1MXhtFKnsbbF 19766757
17. PP Meier HS Gurm 2010 Is simpler also better? Brief sodium bicarbonate infusion to prevent contrast-induced nephropathy Am J Cardiol 105 1042 1043 10.1016/j.amjcard.2009.11.011 20346331 This paper demonstrates the usefulness of a short infusion protocol for sodium bicarbonate that might be useful for patients with ST-segment elevation myocardial infarction
18. H Trivedi S Daram A Szabo, et al. 2009 High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy Am J Med 122 874e9 874e15 10.1016/j.amjmed.2009.01.035
19. G Marenzi E Assanelli I Marana, et al. 2006 N-acetylcysteine and contrast-induced nephropathy in primary angioplasty N Engl J Med 354 2773 2782 10.1056/NEJMoa054209 1:CAS:528:DC%2BD28XmsVKrur0%3D 16807414
20. M Baskurt B Okcun O Abaci, et al. 2009 N-acetylcysteine versus N-acetylcysteine+theophylline for the prevention of contrast nephropathy Eur J Clin Invest 39 793 799 10.1111/j.1365-2362.2009.02173.x 1:CAS:528: DC%2BD1MXhtFSqtb%2FK 19500141
21. M Malhis S Al-Bitar 2010 Al-Deen Zaiat K: The role of theophylline in prevention of radiocontrast media-induced nephropathy Saudi J Kidney Dis Transpl 21 276 283 20228513
22. RG Cigarroa RA Lange RH Williams LD Hillis 1989 Dosing of contrast material to prevent contrast nephropathy in patients with renal disease Am J Med 86 649 652 10.1016/0002-9343(89)90437-3 1:STN:280:DyaL1M3ntVGguw%3D%3D 2729314
23. G Marenzi E Assanelli J Campodonico, et al. 2009 Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality Ann Intern Med 150 170 177 19189906 This paper evaluates the role of contrast volume and CI-AKI
24. • Brown JR, Robb JF, Block CA, Schoolwerth AC, Kaplan AV, O'Connor GT, Solomon RJ, Malenka DJ: Does "safe" dosing of iodinated contrast prevent contrast-induced acute kidney injury? Circ Cardiovasc Interv 2010, 3:1-5.
25. M Reed P Meier UU Tamhane, et al. 2009 The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials JACC Cardiovasc Interv 2 645 654 10.1016/j.jcin.2009.05.002 19628188 This study is a systematic review of the clinical utility of iodixanol (iso-osmolar contrast agent) compared with low-osmolar agents
26. R Wessely T Koppara C Bradaric, et al. 2009 Choice of contrast medium in patients with impaired renal function undergoing percutaneous coronary intervention Circ Cardiovasc Interv 2 430 437 10.1161/CIRCINTERVENTIONS.109. 874933 20031753
27. E Alexopoulos K Spargias S Kyrzopoulos, et al. 2010 Contrast-induced acute kidney injury in patients with renal dysfunction undergoing a coronary procedure and receiving non-ionic low-osmolar versus iso-osmolar contrast media Am J Med Sci 339 25 30 10.1097/MAJ.0b013e3181c06e70 19996728
28. W Laskey P Aspelin C Davidson, et al. 2009 Nephrotoxicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures Am Heart J 158 822 828.e3 10.1016/j.ahj.2009.08.016 1:CAS:528:DC%2BD1MXhtlSqsrjE 19853704
29. R Solomon 2010 Nephrotoxicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures Am Heart J 159 7 10.1016/j.ahj.2009.12.002 author reply e9
30. F Hernandez L Mora J Garcia-Tejada, et al. 2009 Comparison of iodixanol and ioversol for the prevention of contrast-induced nephropathy in diabetic patients after coronary angiography or angioplasty Rev Esp Cardiol 62 1373 1380 10.1016/S1885-5857(09)73531-5 20038403
31. L Bolognese G Falsini S Grotti, et al. 2010 The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study J Cardiovasc Med (Hagerstown) 11 199 206
32. M Maioli A Toso M Leoncini, et al. 2008 Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention J Am Coll Cardiol 52 599 604 10.1016/j.jacc.2008.05.026 1:CAS:528:DC%2BD1cXpvFGgt7k%3D 18702961
33. J Xinwei F Xianghua Z Jing, et al. 2009 Comparison of usefulness of simvastatin 20mg versus 80mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention Am J Cardiol 104 519 524 10.1016/j.amjcard.2009.04.014 19660605
34. G Weisz SJ Filby MG Cohen, et al. 2009 Safety and performance of targeted renal therapy: the Be-RITe! Registry J Endovasc Ther 16 1 12 10.1583/08-2515.1 19281283 This paper demonstrates the use of the Benephit System Renal Infusion Therapy (Be-RITe!)
35. HH Chen A Cataliotti JA Schirger, et al. 2009 Local renal delivery of a natriuretic peptide a renal-enhancing strategy for B-type natriuretic peptide in overt experimental heart failure J Am Coll Cardiol 53 1302 1308 10.1016/j.jacc.2009.01.030 1:CAS:528:DC%2BD1MXktlyqtLk%3D 19358945
36. PS Teirstein MJ Price VS Mathur, et al. 2006 Differential effects between intravenous and targeted renal delivery of fenoldopam on renal function and blood pressure in patients undergoing cardiac catheterization Am J Cardiol 97 1076 1081 10.1016/j.amjcard.2005.10.053 1:CAS:528:DC%2BD28XivVaqtL0%3D 16563920
37. E Grube D Baim D Burkhoff, et al. 2005 Local intra-renal fenoldopam infusion causes greater increases in renal artery flow velocity than systemic intravenous fenoldopam infusion: a pilot study EuroIntervention 1 305 308 19758921
38. EJ Smith O Reitan T Keeble, et al. 2009 A first-in-man study of the Reitan catheter pump for circulatory support in patients undergoing high-risk percutaneous coronary intervention Catheter Cardiovasc Interv 73 859 865 10.1002/ccd.21865 19455649 This paper demonstrates the use of the Reitan catheter pump
39. M Haase R Bellomo P Devarajan, et al. 2009 Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis Am J Kidney Dis 54 1012 1024 10.1053/j.ajkd.2009.07.020 1:CAS:528:DC%2BC3cXkvFKqsA%3D%3D 19850388 This paper systematically reviews the evidence for supporting NGAL as an early biomarker for AKI